Showing results (411-420 of 454) with videos related to
Sort By:
Pageof 46
Blood Advances|September 18, 2025
Poor Outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French studySarah Cayla, Lionel Karlin, Jerome Lambert, et al.Annals of Neurology|October 13, 2020
Characterization of Recessive Parkinson Disease in a Large Multicenter StudySuzanne Lesage, Ariane Lunati, Marion Houot, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 14, 2022
Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS StudyCaroline Houillier, Sylvain Dureau, Luc Taillandier, et al.Blood Advances|August 30, 2021
Outcomes after first-line immunochemotherapy for primary mediastinal B-cell lymphoma: a LYSA studyVincent Camus, Cédric Rossi, Pierre Sesques, et al.Blood|October 29, 2025
Brexucabtagene autoleucel for BTKi-naive relapsed/refractory mantle cell lymphoma: primary analysis of ZUMA-2 Cohort 3Tom van Meerten, Marie José Kersten, Gloria Iacoboni, et al.Blood Advances|August 20, 2024
Outcome of patients with large B-cell lymphoma treated with tafasitamab plus lenalidomide either before or after CAR T-cell therapyVincent Camus, Roch Houot, Gabriel Brisou, et al.Blood Advances|February 24, 2026
Poor outcomes with BCMA-targeting bispecific antibodies following early relapse from ide-cel: a real-world French studySarah Cayla, Lionel Karlin, Jérôme Lambert, et al.Journal of Hepatology|August 14, 2025
Phase I trial of ADP-A2AFP TCR T-cell therapy in patients with advanced hepatocellular or gastric hepatoid carcinomaTim Meyer, Richard S Finn, Mitesh Borad, et al.Journal for Immunotherapy of Cancer|August 30, 2023
Impact of prior therapies and subsequent transplantation on outcomes in adult patients with relapsed or refractory B-cell acute lymphoblastic leukemia treated with brexucabtagene autoleucel in ZUMA-3Bijal D Shah, Ryan D Cassaday, Jae H Park, et al.Brain Communications|August 17, 2021
The wide spectrum of COVID-19 neuropsychiatric complications within a multidisciplinary centreCécile Delorme, Marion Houot, Charlotte Rosso, et al.Pageof 46